Objective: Low-density lipoprotein receptor-related protein-1 (LRP1) has been suggested to be a crucial regulator in the pathogenesis of abdominal aortic aneurysm (AAA) from previous genome association and animal studies. Our prior study using human aortic samples has further revealed a significant reduction of LRP1 protein expression associated with AAA. However, the downregulation of LRP1 in the pathophysiology of AAA remained unresolved. We hypothesized that LRP1 downregulation may be mediated by microRNA (miR) and that LRP1 may function as a scavenger of matrix metalloproteinase-9 (MMP-9), a well-known protease for degradation of extracellular matrix proteins at the aortic wall for AAA pathogenesis. This study investigated the cause of LRP1 downregulation and its potential effect on AAA pathogenesis. Methods: An observational study of LRP1 protein, LRP1 messenger RNA (mRNA), and its three predicted miR candidates (miR-205, miR-338-5p, and miR-545-3p) was first performed in AAA compared with nonaneurysmal tissues from humans, followed by a functional study testing the effect on LRP1 expression of miR-205 overexpression and knockdown in human vascular smooth muscle cells (VSMCs) explant cultured from human abdominal aortic tissues. Lastly, another functional study was performed to test for the clearance of exogenous MMP-9 upon silencing of LRP1 in human VSMCs. Results: From the observational study, significantly higher miR-205 (P < .001) and lower LRP1 protein (P < .001) expressions were found in human AAA tissues compared with nonaneurysmal aortic tissues, and no significant difference in LRP1 mRNA expression was observed. Further statistical analysis showed a significant negative correlation between miR-205 and LRP1 protein expressions (r [ L0.65; P < .01). For the functional study, a significant downregulation of LRP1 protein expression was shown in miR-205-overexpressing VSMCs (P < .05), without any alteration in LRP1 mRNA expression. Moreover, a significantly reduced clearance of exogenous MMP-9 was observed in LRP1-silenced VSMCs (P < .05), and this difference in MMP-9 clearance was completely abolished with a pretreatment of anti-LRP1 antibody. Conclusions: Our study revealed the downregulation of LRP1 protein expression may be tightly regulated by miR-205 through translational inhibition in human VSMCs. Also, such LRP1 down-regulation in VSMCs may hinder the removal of pericellular MMP-9, leading to excess MMP-9 remaining in the extracellular matrix. Hence, the integrity of the vascular wall may be disrupted, promoting AAA formation. (J Vasc Surg 2017;65:509-20.) Clinical Relevance: Low-density lipoprotein receptor-related protein-1 (LRP1) has been suggested to be a lead gene for abdominal aortic aneurysm (AAA) pathogenesis. Its involvement in AAA is still a mystery, however. This study highlighted the importance of tight regulation of LRP1 expression mediated by microRNA-205 for determination of vascular wall integrity through monitoring the pericellular matrix metalloproteinase-9 level. The manipulation of LRP1 expression by microRNA-205 inhibitor may become a new therapeutic prevention of AAA in the future.
The pathogenesis of abdominal aortic aneurysm (AAA) is believed to be multifactorial, and the ultimate causes of AAA still remain unidentified. Previous studies have investigated the association of AAA occurrence and specific gene loci. 1, 2 Of all candidate genes of interest, low-density lipoprotein receptor-related protein-1 (LRP1) has been recently highlighted to be closely associated with AAA. 2 LRP1 is a cell-surface receptor protein that is abundantly expressed in various tissues, including liver, lung, brain, intestine, and muscle. [3] [4] [5] LRP1 is capable of binding to a variety of ligands for endocytosis for various functions. [6] [7] [8] [9] Previous studies have suggested LRP1 may play a role in AAA pathogenesis. 2, 10, 11 A genome-wide association study reported a significant association between a variant in the LRP1 gene and AAA, suggesting that the LRP1 gene may be a lead gene for AAA formation. 2 Two studies in knockout mice showed AAA pathogenic features, such as disruption of elastin, distended and dilated aorta, and aneurysm formation, upon the depletion of LRP1, suggesting a potential role of LRP1 in AAA formation. 10, 11 However, no study had been conducted to investigate the differential expression of LRP1 in human AAA samples.
Consequently, our group took the first step to investigate the protein expression of LRP1 in AAA compared with non-AAA tissues from humans.
12 LRP1 protein expression was significantly reduced in AAA tissues from humans, suggesting such differential expression may be associated with aneurysm. 12 Although a reduced LRP1 protein expression was suggested to be associated with AAA, the cause and effect of such down-regulation in aortic tissue for AAA pathogenesis remain unresolved. By investigating the cascade of LRP1 downregulation for AAA pathogenesis, therapeutic strategies for targeting the origin of the LRP1-mechanistic pathway may be introduced to prevent AAA formation. This study therefore investigated the cause of LRP1 downregulation and its potential effect on AAA pathogenesis.
The first part of this study investigated the cause of LRP1 downregulation in AAA. LRP1 protein expression has been proposed to be mediated by microRNA (miR/ miRNA), a small RNA molecule binding to its target messenger RNA (mRNA) for downregulation through mRNA degradation or translational inhibition. [13] [14] [15] Three miRNA candidatesdmiR-205, miR-338-5p, and miR-545-3pdwere predicted to have the highest potential to bind to LRP1 mRNA from a bioinformatics analysis using a target miRNA prediction program called mirDB.
14 That miR-205 may downregulate LRP1 protein expression through translational inhibition in certain human cancer cell lines has also been suggested. 14, 15 We therefore hypothesized that the reduced LRP1 protein expression in human AAA tissues may be mediated by miR-205.
An observational study was first performed to investigate the expression levels of LRP1 mRNA, miR-205, miR-338-5p, and miR-545-3p in AAA compared with nonaneurysmal aortic tissues from humans. A functional study then followed to test for the effect of miRNA overexpression and knockdown on LRP1 expression in vascular smooth muscle cells (VSMCs) cultured from human abdominal aortic tissues.
The second part of this study investigated the potential effect of LRP1 downregulation in AAA. LRP1 has been proposed to act as a scavenger of pericellular matrix metalloproteinase-9 (MMP-9), a well-known protease abundantly expressed in the extracellular matrix (ECM) of the aortic wall for degradation of elastin and, hence, aneurysm formation. [16] [17] [18] [19] A study demonstrated reduced internalization and degradation of MMP-9 in a mouse embryonic fibroblast cell line with LRP1 depletion. 16 We therefore hypothesized that LRP1 expressed on VSMCs from human abdominal aortic tissues may mediate the clearance of extracellular MMP-9. A functional study was performed to investigate the clearance of exogenous MMP-9 upon silencing of LRP1 in human VSMCs.
METHODS
All experiments in this study were performed with approval from the local institution's Ethics Committee.
Collection of human abdominal aortic tissue specimens. Full-thickness aneurysmal infrarenal abdominal aortic tissues were excised during open surgical aneurysmal repair at the point of maximum aortic dilatation from eight AAA patients (4 men and 4 women) who were a mean 6 standard deviation age of 65.63 6 9.52 years and were free from connective tissue disorders (ie, Marfan syndrome and Ehlers Danlos syndrome). For the control group, full-thickness nonaneurysmal infrarenal abdominal aortic tissues were dissected out from eight organ donors (3 men and 5 women; mean age, 55.88 6 9.75 years), without known cardiovascular diseases or connective tissue disorders, during liver harvesting for transplantation. This batch was only sufficient for the observational study. Another batch of aortic tissues was used for the functional study. Full-thickness nonaneurysmal infrarenal abdominal aortic tissues of six male organ donors (mean age, 48.50 6 13.59 years), without known cardiovascular diseases or connective tissue disorders, were dissected out during liver harvesting for transplantation.
Demographic data are reported in the Table. All relevant clinical data were obtained from the clinical medical record system. Informed consents for obtaining human specimens for research were obtained.
Western blotting. Proteins extracted by radioimmunoprecipitation lysis buffer (Cell Signaling Technology, Danvers, Mass) with 1mM phenylmethanesulfonyl fluoride (Sigma-Aldrich, St. Louis, Mo), according to the manufacturer's protocol, were resolved by sodium dodecyl sulfatepolyacrylamide gel electrophoresis (Bio-Rad Laboratories, Hercules, Calif). The gel was electroblotted to a polyvinylidene difluoride membrane (GE Healthcare, Little Chalfont, United Kingdom) at 100 volts for 2 hours at 4 C. The membrane was probed with the following primary antibodies: LRP1 (1:6000; Cat. No. ab28320, Abcam, Cambridge, United Kingdom) and MMP-9 (1:5000; Cat. No. NBP1-40610, Novus Biologicals, Littleton, Colo), with glyceraldehyde-3-phosphate dehydrogenase (1:10000; Cat. No. 2118, Cell Signaling Technology, Danvers, Mass) as the internal control.
Incubation followed with horseradish peroxidaseconjugated goat anti-rabbit or mouse immunoglobulin G (1:10000; Invitrogen, Carlsbad, Calif) for 1 hour at room temperature. The ECL Prime detection system (GE Healthcare) was used for exposure to X-ray film (Fujifilm, Tokyo, Japan). Band intensity developed on X-ray film was analyzed by ImageJ 1.46 software (National Institutes of Health, Bethesda, Md).
Real-time quantitative reverse-transcription polymerase chain reaction. Total RNA was extracted by miRNeasy Mini kit (QIAGEN, Venlo, The Netherlands), followed by the first-strand synthesis using the miScript RT kit (QIAGEN) in 2720 Thermal Cycler (Applied Biosystems, Foster City, Calif). Quantitative polymerase chain reaction was performed in a 7900HT Fast Real-Time PCR System (Applied Biosystems) according to the protocol of the miScript SYBR Green PCR kit (QIAGEN) using primers specific to LRP1 and glyceraldehyde-3-phosphate dehydrogenase as the internal control; miR-205, miR-338-5p, miR-545-3p and RNU6-2 as the internal control (Invitrogen, Carlsbad, Calif). 20, 21 The experiment was performed in duplicate. The 2
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method was used to analyze the data. 22, 23 Explant culture of VSMCs from human abdominal aortic tissues. Aortic tissue specimens collected for the functional study were thoroughly washed with Dulbecco's Modified Eagle Medium (Life Technologies, Carlsbad, Calif) before explant culture. A segment sized w2-Â 2-mm was dissected out from each aortic tissue specimen and placed onto a complete cell culture medium containing Dulbecco's modified eagle medium, 10% fetal bovine serum, 2mM L-alanyl-L-glutamine dipeptide, 100 U/mL penicillin, 100 mg/mL streptomycin, and 20mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (Life Technologies), followed by incubation at 37 C in a humidified 5% CO 2 atmosphere for w1 to 2 weeks with regular replacement of complete cell culture medium in every 3 days. Cells growing out from the aortic tissue segment were passaged before reaching confluence. The homogeneity of cultured VSMCs was confirmed by immmunocytochemical staining of smooth muscle a-actin with antihuman smooth muscle a-actin antibody (1:200; Cat.
No. M0851, DakoCytomation, Glostrup, Denmark). Overexpression and knockdown of miR-205 in human VSMCs. The explant cultured VSMCs were transfected with mirVana miRNA mimic and inhibitor (Life Technologies) for hsa-miR-205-5p overexpression and knockdown, respectively, using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) according to the manufacturer's protocol. The miR-205 mimic is a small RNA that mimics the endogenous miR-205, resulting in an increase in the downregulation of its target gene. The miR-205 inhibitor is a small RNA that specifically binds to and inhibits the endogenous miR-205, resulting in a decrease in the downregulation of its target gene. The corresponding negative controls (Life Technologies) for mimic and inhibitors were also transfected as scramble controls. Fresh complete cell culture medium was replaced after the first 24-hour incubation, followed by further 48-hour incubation before cells were harvested for analysis of miR-205 and LRP1 mRNA expressions by real-time quantitative reversetranscription polymerase chain reaction and analysis of LRP1 protein expression by Western blotting (WB).
LRP1 silencing in human VSMCs. The explant cultured VSMCs were transfected with Silencer validated small interfering RNA (siRNA) (Life Technologies) for LRP1 silencing using Lipofectamine RNAiMAX Transfection Reagent (Life Technologies) according to the manufacturer's protocol. This siRNA of LRP1 is a small RNA that specifically targets the endogenous LRP1 mRNA, resulting in a reduction of LRP1 protein expression. The corresponding negative control (Life Technologies) for siRNA was also transfected as scramble control. Fresh complete cell culture medium was replaced after the first 24-hour incubation, followed by a further 48-hour incubation before cells were harvested for analysis of LRP1 and MMP-9 expressions by WB, and harvest of conditioned Analysis of the relative expression of three microRNA (miR) in human abdominal aortic tissues in abdominal aortic aneurysm (AAA; n ¼ 8) and control (n ¼ 8) abdominal aortic tissues from humans by quantitative reverse-transcription polymerase chain reaction. A, miR-205 expression in AAA (mean, 3.48 6 1.20) was significantly higher than that in control (mean, 1.14 6 0.63) aortic tissues (P < .001). B, No significant difference was observed in miR-338-5p expression between AAA (mean, 1.18 6 0.45) and control (mean, 1.07 6 0.38) aortic tissues (P ¼ .61). C, No significant difference was observed in miR-545-3p expression between AAA (mean, 1.13 6 0.30) and control (mean, 1.07 6 0.40) aortic tissues (P ¼ .73). media concentrated by Amicon Ultra-0.5 Centrifugal Filter Devices (Millipore Corp, Billerica, Mass) for analysis of MMP-9 level by WB.
Analysis of clearance of exogenous MMP-9 in LRP1-silenced VSMCs. LRP1-silenced VSMCs were pretreated in the presence or absence of antibody against the extracellular domain of LRP1 (10 mg/mL; Cat. No. ab20384, Abcam) at 37 C in a humidified 5% CO 2 atmosphere for 1 hour, followed by replacement of fresh complete cell culture medium with 1nM human MMP-9 full-length protein (Abcam), which is an optimized concentration from a trial experiment performed using concentrations of 0.5, 1, 2, and 5nM. Cells were then incubated at 37 C in a humidified 5% CO 2 atmosphere for 6 hours, followed by trypsinization for cell counting by hematocytometer (Marienfeld-Superior, Baden-Württem-berg, Germany). MMP-9 remained in conditioned media was concentrated by Amicon Ultra-0.5 Centrifugal Filter Devices (Millipore Corp) and was analyzed by WB. The change of exogenous MMP-9 level in conditioned media was determined by comparing with the basal exogenous MMP-9 level, which was a control performed under the same experimental setting without VSMCs.
Statistical analysis. SPSS 20.0 software (IBM Corp, Armonk, NY) was used for statistical analysis. The ShapiroWilk test was used to test for the normality of AAA and control groups. An independent-samples t-test was used to investigate the statistical difference in relative expressions of LRP1 protein, LRP1 mRNA, and miRNAs between AAA and control groups. A linear model was used to correct for age and gender. A Pearson correlation coefficient was calculated to assess the correlation between LRP1 protein and miR-205 expressions. The Wilcoxon signed rank test was used to investigate the statistical difference in relative expressions between the experimental and control groups. The data are expressed as mean 6 standard deviation. The level of significance was set at P < .05.
RESULTS
Lower LRP1 protein but similar LRP1 mRNA expressions in AAA compared with control aortic tissues. LRP1 protein expression was investigated to validate our previous finding with a completely new batch of AAA and control aortic tissues. 12 The relative LRP1 protein expression in AAA (n ¼ 8; 0.55 6 0.21) was significantly reduced compared with that in control (n ¼ 8; 0.99 6 0.10) aortic tissues (P < .001), and this differential LRP1 expression between AAA and control groups was robust to correction for age and gender in a linear model (P < .001). This finding of using a new batch of tissues is in agreement with the previous finding showing a reduced LRP1 protein expression in human AAA tissues. 12 The LRP1 mRNA expression level was detected in the AAA and control aortic tissues (Fig 1) . The relative LRP1 mRNA expression level in AAA (n ¼ 8; 1.00 6 0.46) was similar to that in control (n ¼ 8; 1.02 6 0.29) aortic tissues, showing no significant difference (P ¼ .90). This finding remained insignificant after correction for age and gender (P ¼ .54).
Higher miR-205 but similar miR-338-5p and miR-545-3p expressions in AAA compared with control aortic tissues. The expression levels of the 3 miRNA candidates were detected in the AAA and control aortic tissues (Fig 2) . The relative miR-205 expression level in AAA (n ¼ 8; 3.48 6 1.20) was significantly higher than that in control (n ¼ 8; 1.14 6 0.63) aortic tissues (P < .001; Fig 2,  A) , and such differential miR-205 expression between AAA and control groups was robust to correction for age and gender in a linear model (P < .01). No significant difference in the relative miR-338-5p expression was observed between AAA (n ¼ 8; 1.18 6 0.45) and control (n ¼ 8; 1.07 6 0.38) aortic tissues (P ¼ .61; Fig 2, B) and remained insignificant after correction for age and gender (P ¼ .06). No significant difference in the relative miR-545-3p expression was observed between AAA (n ¼ 8; 1.13 6 0.30) and control (n ¼ 8; 1.07 6 0.40) aortic tissues (P ¼ .73; Fig 2, C) and remained insignificant after correction for age and gender (P ¼ .26). The relative LRP1 protein expression in VSMCs with miR-205 overexpression (mean, 0.68 6 0.15) was significantly lower than that in control VSMCs (mean, 1 6 0; n ¼ 6; P < .05) (bottom left). The relative LRP1 protein expression in VSMCs with miR-205 knockdown (mean, 1.57 6 0.25) was significantly higher than that in control VSMCs (mean, 1 6 0; n ¼ 6; P < .05) (bottom right). The error bars show the standard deviation. GAPDH, Glyceraldehyde-3-phosphate dehydrogenase.
Significant negative correlation between LRP1 protein and miR-205 expressions from aortic tissues. Because the findings showed a significantly lower LRP1 protein expression and a significantly higher miR-205 expression in AAA compared with control aortic tissues, a Pearson correlation coefficient was calculated to assess the correlation between LRP1 protein and miR-205 expressions (Fig 3) . A significant negative correlation (r ¼ À0.65) was observed between the LRP1 protein and miR-205 expression levels (n ¼ 16; P < .01).
Downregulation of LRP1 protein expression by miR-205 in human VSMCs from abdominal aortic tissues. Of the three miRNA candidates, only miR-205 was differentially expressed in AAA tissues while showing a significant negative correlation with LRP1 protein expression. Consequently, a functional study was performed to test for the effect of miR-205 overexpression and knockdown on LRP1 expression in VSMCs cultured from human abdominal aortic tissues. miR-205 was transiently overexpressed and knocked down in human VSMCs. The success of overexpression and knockdown of miR-205 in VSMCs upon transfection of its mimic and inhibitor was validated by relative quantification of miR-205 expression level, showing an average twofold increase and decrease, respectively (Fig 4) .
The effect on LRP1 mRNA and protein expressions in VSMCs on miR-205 overexpression and knockdown was investigated (Fig 5) . No significant difference in the relative LRP1 mRNA expression was observed between miR-205 overexpression (0.99 6 0.03) and control (1 6 0) VSMCs (n ¼ 6; P ¼ .46; Fig 5, A) . Likewise, no significant difference in the relative LRP1 mRNA expression was observed between miR-205-knockdown (0.99 6 0.03) and control (1 6 0) VSMCs (n ¼ 6; P ¼ .92; Fig 5, A) . However, the relative LRP1 protein expression in VSMCs with miR-205 overexpression (0.68 6 0.15) was significantly lower than in control VSMCs (n ¼ 6; 1 6 0; P < .05), whereas the relative LRP1 protein expression in VSMCs with miR-205 knockdown (1.57 6 0.25) was significantly higher than that in control VSMCs (n ¼ 6; 1 6 0; P < .05; Fig 5, B) . These suggested that LRP1 protein expression was tightly regulated by miR-205 through translational inhibition in VSMCs from human abdominal aortic tissues.
Pericellular MMP-9 clearance mediated by LRP1 on human VSMCs from abdominal aortic tissues. Because LRP1 protein expression was downregulated in AAA tissues, the effect of such downregulation is believed to be related to AAA pathogenesis. Therefore, the hypothesized role of LRP1 in the clearance of pericellular MMP-9 was investigated upon silencing of LRP1 in human VSMCs.
The LRP1 protein expression was first transiently silenced in human VSMCs explants cultured from abdominal aortic tissues. The success of LRP1 silencing in VSMCs upon transfection of siRNA of LRP1 was validated by relative quantification of LRP1 protein expression, showing an average of 2.6-fold decrease (Fig 6) . In addition, no detectable MMP-9 protein was observed in VSMCs transfected with siRNA of LRP1 or the corresponding control. Similarly, no detectable MMP-9 protein was observed in their conditioned media. These results suggested that MMP-9 protein expression was not induced by LRP1 downregulation.
Next, the LRP1-silenced VSMCs were incubated with exogenous MMP-9 proteins in the absence or presence of anti-LRP1 antibody pretreatment (Fig 7) . In the absence of antibody pretreatment, results showed the relative amount of exogenous MMP-9 that remained in conditioned media of LRP1-silenced VSMCs (50.03% 6 25.14%) was significantly higher than that of control VSMCs (n ¼ 6; 15.58% 6 2.39%; P < .05; Fig 7, A) . However, in the presence of antibody pretreatment, no significant difference in the relative amount of exogenous MMP-9 remained in conditioned media was shown between LRP1-silenced (99.43% 6 1.41%) and control (99.52% 6 1.48%) VSMCs (n ¼ 6; P ¼ .92; Fig 7, B) . These results suggested that downregulation of LRP1 protein expression in VSMCs may result in a decreased MMP-9 clearance and that such clearance of MMP-9 may be specifically mediated by LRP1.
DISCUSSION
The downregulation of LRP1 has been highlighted to be associated with AAA from previous studies. This study investigated the cause of such downregulation and its potential effect for AAA pathogenesis. Our findings showed LRP1 protein expression was downregulated by miR-205, and this reduction of LRP1 protein expression in human VSMCs resulted in a reduced clearance of pericellular MMP-9. This cascade of LRP1 downregulation in aortic tissues is indicative of the disruption of vascular wall integrity leading to AAA formation.
This study first began with the investigation of the cause of LRP1 downregulation in AAA tissues. Consistent with our prior published study, a significant reduction of LRP1 protein expression was observed in AAA tissue compared with nonaneurysmal aortic tissues from humans. 12 However, no significant difference in LRP1 mRNA expression was shown between the two groups. This suggested that the downregulation of LRP1 protein expression in AAA tissues is unlikely to be caused by transcriptional inhibition of the LRP1 gene into mRNA or degradation of the transcribed LRP1 mRNA. Therefore, it was hypothesized that such downregulation may be caused by translational inhibition of LRP1 mRNA into protein mediated by miRNAs. 14, 15 To test this hypothesis, the endogenous expressions of three predicted miRNA candidates (ie, miR-205, miR-338-5p, and miR-545-3p) were investigated in the AAA and control aortic tissues to look for the differentially expressed miRNA candidate associated with AAA.
14 Of the three miRNA candidates, only miR-205 was differentially expressed, showing an overexpression in human AAA tissues. More importantly, further statistical analysis showed a significant negative correlation between the miR-205 and LRP1 protein expressions. Therefore, miR-205 is likely to be a candidate for downregulation of LRP1 protein expression in human AAA tissues. in the conditioned media. The band of no-VSMC control, which was performed in the same experimental setting with the absence of VSMCs, was used as the basal exogenous MMP-9 level (upper). The percentage of exogenous MMP-9 remained in the conditioned media of VSMCs with LRP1 silencing (mean, 50.03% 6 25.14%) was significantly higher than that of control VSMCs (mean, 15.58% 6 2.39%; n ¼ 6; P < .05) (bottom). B, Representative WB of an individual sample of VSMCs with LRP1 silencing compared with control, probing for MMP-9 in the conditioned media. The band of no-VSMC control, which was performed in the same experimental setting with the absence of VSMCs, was used as the basal exogenous MMP-9 level (upper). No significant difference was observed in the percentage of exogenous MMP-9 remained in the conditioned media between LRP1 silenced (mean, 99.43% 6 1.41%) and control (mean, 99.52% 6 1.48%) VSMCs (n ¼ 6; P ¼ .92) (bottom). The error bars show the standard deviation.
A functional study was conducted to test for the effect of miR-205 overexpression and knockdown on LRP1 expression in VSMCs. Results showed a downregulated LRP1 protein expression in miR-205-overexpressing VSMCs, and an upregulated LRP1 protein expression was observed in miR-205-knockdown VSMCs. Moreover, consistent with the finding from the above observational study, LRP1 mRNA expression was not altered upon miR-205 overexpression or knockdown. Therefore, these findings suggested that miR-205 may downregulate LRP1 protein expression through translational inhibition in VSMCs from human abdominal aortic tissues.
The second part of this study investigated the effect of LRP1 downregulation in VSMCs. A functional study was performed to investigate the clearance of exogenous MMP-9 upon silencing of LRP1 in human VSMCs. Although the transfection of siRNA of LRP1 in human VSMCs did not lead to a complete knockdown of LRP1 expression, an average of 2.6-fold reduction in LRP1 protein expression was still observed compared with scramble control. Then, LRP1-silenced and control VSMCs were both incubated with exogenous MMP-9 in the absence or presence of anti-LRP1 antibody pretreatment. In the absence of antibody pretreatment, results showed significantly more exogenous MMP-9 remained in conditioned media of LRP1-silenced VSMCs (50.03%) compared with control VSMCs (15.58%). This suggested that the amount of MMP-9 depleted depends on the LRP1 protein expression level in VSMCs, indicating LRP1 is involved in the clearance of exogenous MMP-9. However, in the presence of anti-LRP1 antibody, which specifically binds to and blocks the extracellular domain of LRP1 on VSMCs, nearly all MMP-9 remained in the media of both LRP1-silenced (99.43%) and control (99.52%) VSMCs. This indicated that no MMP-9 was depleted in the presence of antibody pretreatment.
Thus, this functional study provided direct evidence that clearance of MMP-9 is LRP1-dependent and implicated that LRP1 expressed on human VSMCs may function as a scavenger of pericellular MMP-9. In addition, this study may also help explain the observations in previous animal studies showing elevated MMP-9 level together with disruption of elastin at the dilated aorta of smooth muscle LRP1-knockout mice. 10, 11 The tight regulation of LRP1 protein expression mediated by miR-205 seems to be specific in human VSMCs, which is the most abundant cell type in the aortic wall. Another cell type in the aortic wall (ie, endothelial cells) may not have the same regulatory mechanism because an animal study reported that miR-205 in mouse endothelial cells promoted AAA by downregulating 2 MMP suppressors (ie, tissue inhibitor of matrix metalloproteinase 3 and reversion-inducing cysteine-rich protein with kazal motifs) but not LRP1. 24 This brings out a possibility that miR-205 in different cell types in aortic wall may regulate different targets for AAA pathogenesis.
In this study, no detectable MMP-9 protein was observed in VSMCs transfected with siRNA of LRP1 or corresponding control. Similarly, no detectable MMP-9 protein was observed in the conditioned media. These observations suggested that MMP-9 protein expression was not induced by LRP1 downregulation in VSMCs. However, LRP1 downregulation in another cell type (ie, macrophages) may induce MMP-9 expression because a study using mouse macrophages reported increased MMP-9 expression and secretion upon deletion of LRP1, resulting in a higher frequency of elastin fragmentation. 25 Therefore, macrophages infiltrated into the abdominal aortic wall may possibly have a role in activation of MMP-9 expression induced by LRP1 downregulation for AAA pathogenesis.
Regarding the functional study of MMP-9 clearance upon LRP1 silencing, a trial experiment investigated the optimized concentration of MMP-9 added to VSMCs because there is no such study in human VSMCs except by Hahn-Dantona et al 16 using 5nM MMP-9 on a mouse embryonic fibroblast cell line. Among the tested concentrations of 0.5, 1, 2, and 5nM, 2 and 5nM MMP-9 were too high in protein amount for loading in WB and required a longer incubation time for clearance. However, 0.5 and 1nM both showed similar results without the overloading problem in WB. Therefore, 1nM MMP-9 was chosen, which showed the best result with minimal pipetting error. In addition, WB, which is a typical method of semiquantification of protein level, was chosen for analysis of MMP-9 level due to its low cost and high reliability. However, another method, such as enzyme-linked immunosorbent assay, which allows absolute quantification of MMP-9, should be used in future large-scale studies to simplify the experimental procedure and validate the current finding.
In addition, it is still uncertain whether LRP1 can clear any other ECM proteases, like MMP-2, in human VSMCs because clearance of MMP-2 in complex with thrombospondin or tissue inhibitor of metalloproteinase-2 can be accomplished by LRP1 together with coreceptors in dermal fibroblasts and fibrosarcoma cells. 26, 27 Therefore, further study can be conducted to detect the clearance of exogenous MMP-2 in human LRP1-silenced VSMCs. Furthermore, LRP1 protein expression was observed not only in the medial layer but also in the adventitial layer of human AAA wall. 12 Because the identity of the cells expressing LRP1 in the adventitial layer remains unresolved, identification of those cells should be done for a further investigation of their involvement in MMP-9 clearance.
A recent animal study reported that angiotensin II infusion promoted dilation in the ascending aorta and superior mesenteric artery in LRP1-depleted mice. 28 However, no dilation was observed in the abdominal aorta, possibly because normocholesterolemic mice were used, which were reported to exhibit a higher resistance to develop AAA by angiotensin II than hypercholesterolemic mice. [28] [29] [30] [31] Therefore, further investigation using hypercholesterolemic mice is necessary to validate the role of LRP1 downregulation in AAA formation.
This study has a limitation of small sampling size because human abdominal aortic tissue specimens are becoming scarce due to the prevalence of endovascular aneurysm repair over open surgery. 32 More patients should be included for validation of current findings. In addition, AAA patients, with and without statin therapy, should be included for investigation of miR-205 and LRP1 protein expression because there is still no report showing statin therapy can modulate miR-205 or LRP1 expression in AAA. More importantly, VSMCs cultured from human AAA tissues should also be included in the future for validation of findings from functional studies, although the passage of AAA VSMCs is generally more difficult because they tend to have a limited in vitro life span compared with nonaneurysmal VSMCs. 33 
CONCLUSIONS
This study suggested that the reduced LRP1 protein expression in human AAA tissues may be tightly regulated by miR-205 through translational inhibition and that such LRP1 downregulation in VSMCs from human abdominal aortic tissues may result in a reduced clearance of pericellular MMP-9. Therefore, it is proposed that LRP1 protein expression tightly regulated by miR-205 is crucial for AAA pathogenesis because the LRP1 expressed on human VSMCs may determine MMP-9 level in ECM of the aortic wall, possibly monitoring proteolytic degradation of elastin and aneurysm formation (Fig 8) . This proposed mechanism is necessary to be investigated in an in vivo model. Although this study is an in vitro model, this shows the importance of tight regulation of LRP1 expression mediated by miR-205 in VSMCs for the determination of vascular wall integrity through monitoring MMP-9 level in ECM. This study also provides an insight on the potential therapeutic strategy of LRP1 up-regulation by miR-205 inhibitor for prevention of AAA.
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